5/2025 Amendment and Execution of Loan Agreements with BioFund

Current Report No: 4/2025 Date: April 15, 2025 Legal Basis: Article 17(1) of Regulation (EU) No 596/2014 of the European Parliament and of the Council (MAR) – inside information   The Management Board of Medicalgorithmics S.A., with its registered office in Warsaw (the “Company”), hereby announces that on April 15, 2025, it entered into a […]

4/2025 Medicalgorithmics Signs Fourth Service Agreement for a Clinical Study with a Canadian Institute, Projecting a Total Revenue of EUR 580K by 2026 

Current Report No: 4/2025 Date: Febraury 4, 2025. Legal Basis: Article 17(1) of the MAR Regulation – Confidential Information The Management Board of Medicalgorithmics S.A., headquartered in Warsaw (the “Company”; the “Issuer”), announces the signing of a service agreement (the “Agreement”) with Hamilton Health Sciences Corporation (“HHSC”) through the Population Health Research Institute (“PHRI”; the […]

3/2025 Correction – Schedule of Periodic Reports for 2025

Current Report No: 3/2025 Date: February 2, 2025. Legal Basis: Article 56(1)(2) of the Act on Public Offering – Current and Periodic Information The Management Board of Medicalgorithmics S.A., based in Warsaw (the “Company”), corrects an obvious clerical error in current report No. 1 dated January 22 of this year and clarifies that the standalone […]

2/2025 Medicalgorithmics S.A. Signs Contract with US IDTF with Estimated Revenue Potential of up to PLN 46 Million Over Two Years

Current Report No: 2/2025 Date: January 24, 2025. Legal Basis: Article 17(1) of the MAR Regulation – Confidential Information Medicalgorithmics S.A., headquartered in Warsaw (the “Company”; the “Issuer”), announces that on January 24, 2025, it signed a significant agreement (the “Agreement”) with a U.S.-based diagnostic center (IDTF, the “Partner”). The signing of this Agreement is […]

1/2025 Schedule of Periodic Reports for 2025

Current Report No: 1/2025 Date: January 22, 2025. Legal Basis: Article 56(1)(2) of the Act on Public Offering – Current and Periodic Information The Management Board of Medicalgorithmics S.A., headquartered in Warsaw (the “Company”), hereby announces the schedule for the publication of periodic reports in 2025: 1.Standalone Annual Report and Consolidated Annual Report for 2023 […]

22/2024 Information on the Completion of the CE Certification Process for VCAST Technology by Medicalgorithmics S.A.

Current Report No: 22/2024 Date: 17.10.2024 r. Legal Basis: Article 17(1) of the MAR Regulation – confidential information. The Management Board of Medicalgorithmics S.A., based in Warsaw (“Company”; “Issuer”), informs that the Company has received notification from the notified body TÜV Rheinland Polska Sp. z o.o. regarding the successful completion of the CE certification process […]

21/2024 Change of the publication date of the semi-annual report for the first half of 2024

Current Report No: 21/2024 Date: 20.08.2024 r. Legal Basis: Article 56(1)(2) of the Act on Public Offering – current and periodic information The Management Board of Medicalgorithmics S.A., based in Warsaw (the “Company”), hereby announces a change in the publication date of the semi-annual report for the first half of 2024 (the “Report”). The Report […]

20/2024 Assimilationof Series J Shares of the Company with Shares Traded on the Main Market

Current Report No: 20/2024 Date: 19.09.2024 r. Legal Basis: Article 56_1__2_ of the Act on Public Offering – Current andPeriodic Information   The Management Board of Medicalgorithmics S.A., based in Warsaw _the “Company”_, in reference to the Company’s current report No. 19/2024 dated September 13, 2024, hereby announces that it has receivedinformation regarding the issuance […]

19/2024 Admissionand conditional introduction of the Company’s series J shares to tradingon the main market of the WSE. Setting the date of the first listing ofthe Company’s series J shares after their assimilation with sharestraded on the main market.

Current Report No: 19/2024 Date: 13.09.2024 r. Legal Basis: Article 56_1__2_ of the Act on Public Offering – Current andPeriodic Information The Management Board of Medicalgorithmics S.A. with its registered office in Warsaw _the “Issuer”, the “Company”_, hereby announces that on 13 September 2024 it received information on the adoption of Resolution No. 1134/2024 of […]

18/2024 Notification of the receipt by Medicalgorithmics S.A. of USD 0.6 million from the React Group as a price adjustment for the sale of Medi-LynxDate

Current Report No: 18/2024 Date: 20.08.2024 r. Legal Basis: Article 17, Section 1 of the MAR Regulation – Confidential Information The Management of Medicalgorithmics S.A., based in Warsaw the “Company”, announces that in reference to the Company’s current report No. 3/2024, on August 20, 2024, the Company received USD 0.6 million approx. 2.3 million PLN from […]

17/2024 Conversion of Registered Series J Shares to Bearer Shares

Current Report No: 17/2024 Date: 19.08.2024 r. Legal Basis: Article 17, Section 1 of the MAR Regulation – Confidential Information The Management of Medicalgorithmics S.A., based in Warsaw “Company”, informs that on August 19, 2024, a resolution was adopted regarding the conversion of registered ordinary Series J shares into bearer ordinary shares “Resolution”. By virtue of […]

16/2024 Information on Medicalgorithmics S.A.’s Agreement to Establish a LoanLine with BioFund Capital Management LLC

Current Report No: 16/2024 Date: 26.06.2024 r. Legal Basis: Article 17, Section 1 of the MAR Regulation – Confidential Information The Management Board of Medicalgorithmics S.A., based in Warsaw “Company”, announces the signing of an agreement on June 25, 2024, to establish a loan line “Agreement” with the Company’s shareholder, BioFund Capital Management LLC “BioFund”. The […]

DeepRhythm Platform (DRP)

Get Your Free Consultation, 
Custom Tailored To Your Needs.
The data administrator is Medicalgorithmics S.A. with its registered office in Warsaw (02-001) at Al. Jerozolimskie 81. The data will be processed in order to answer the query sent (legal basis: legitimate interest of the administrator), marketing (legal basis: legitimate interest of the administrator). The full text of the clause can be found on the Privacy Policy page.

The wait is almost over!

DRAI MARTINI study is set to be published soon. Be the first to know when it lands.
The data administrator is Medicalgorithmics S.A. with its registered office in Warsaw (02-001) at Al. Jerozolimskie 81. The data will be processed in order to answer the query sent (legal basis: legitimate interest of the administrator), marketing (legal basis: legitimate interest of the administrator). The full text of the clause can be found on the Privacy Policy page.

Your submission was succesfull

Software

Get more information
The data administrator is Medicalgorithmics S.A. with its registered office in Warsaw (02-001) at Al. Jerozolimskie 81. The data will be processed in order to answer the query sent (legal basis: legitimate interest of the administrator), marketing (legal basis: legitimate interest of the administrator). The full text of the clause can be found on the Privacy Policy page.

VCAST

Get a free demo
The data administrator is Medicalgorithmics S.A. with its registered office in Warsaw (02-001) at Al. Jerozolimskie 81. The data will be processed in order to answer the query sent (legal basis: legitimate interest of the administrator), marketing (legal basis: legitimate interest of the administrator). The full text of the clause can be found on the Privacy Policy page.

DeepRhythmAI (DRAI)

Get Your Free Consultation, 
Custom Tailored To Your Needs.
The data administrator is Medicalgorithmics S.A. with its registered office in Warsaw (02-001) at Al. Jerozolimskie 81. The data will be processed in order to answer the query sent (legal basis: legitimate interest of the administrator), marketing (legal basis: legitimate interest of the administrator). The full text of the clause can be found on the Privacy Policy page.

Our company

About us

Our History

Management Team

Partners

Career

Work with us

Job offers

Recommend an employee

Application form